UPDATE 1-Swiss drugmaker Actelion upgrades full-year forecast despite profit miss By: Reuters: Company News July 21, 2015 at 02:20 AM EDT * H1 operating income 344 mln Sfr vs Rtrs poll avg 366 mln Sfr Read More >> Related Stocks: Bay National Corp Merck & Co